Aurora Cannabis (ACB) Change in Working Capital (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Change in Working Capital of $330.5 million for Q1 2026, down 10.05% year-on-year from $367.5 million in Q1 2025, and up 10.21% on a QoQ basis from $299.9 million in Q4 2025.
Aurora Cannabis (ACB) Change in Working Capital (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Change in Working Capital for 9 consecutive years, with $330.5 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Working Capital fell 10.05% year-over-year to $330.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 172.42% YoY) and the FY2026 annual result came in at $6.7 million, down 53.06% from the prior year.
- Change in Working Capital improved to $330.5 million in Q1 2026 per ACB's latest filing, from $299.9 million in the prior quarter.
- Over the last five years, Change in Working Capital for ACB reached as high as $367.5 million in Q1 2025 and fell as low as -$21.7 million in Q3 2024.
- A 5-year average of $80.4 million and a median of $15.4 million in 2024 frame the typical range for Change in Working Capital.
- Annual changes were most pronounced in 2022 — Change in Working Capital plunged 197.5% — and 2025, when it soared 2286.66%.
- Year by year, Change in Working Capital stood at -$18.7 million in 2022, then surged by 129.73% to $5.6 million in 2023, then soared by 261.8% to $20.1 million in 2024, then jumped by 1391.53% to $299.9 million in 2025, then rose by 10.21% to $330.5 million in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered $330.5 million, $299.9 million, and $367.5 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -617.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 330.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330.52 Mn |
| Mar 31, 2026 | 330.52 Mn |
| Dec 31, 2025 | 299.90 Mn |
| Dec 31, 2025 | 299.90 Mn |
| Mar 31, 2025 | 367.47 Mn |
| Mar 31, 2025 | 367.47 Mn |
| Dec 31, 2024 | 20.11 Mn |
| Dec 31, 2024 | 20.11 Mn |
| Sep 30, 2024 | -21.69 Mn |
| Sep 30, 2024 | -21.69 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Dec 31, 2023 | 5.56 Mn |
| Dec 31, 2023 | 5.56 Mn |
| Sep 30, 2023 | -11.03 Mn |
| Sep 30, 2023 | -11.03 Mn |
| Dec 31, 2022 | -18.69 Mn |
| Dec 31, 2022 | -18.69 Mn |